Literatur
-
1
Rothdach A J, Trenkwalder C, Haberstock J. et al .
Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and morbidity in Augsburg elderly.
Neurology.
2000;
54
1064-1068
-
2
Krishnan P R, Bhatia M, Behari M.
Restless legs syndrome in Parkinson's disease: a case-controlled study.
Mov Disord.
2003;
18
181-185
-
3
Ondo W G, Vuong K D, Jankovic J.
Exploring the relationship between Parkinson disease and restless legs syndrome.
Arch Neurol.
2002;
59
421-424
-
4
Schols L, Haan J, Riess O. et al .
Sleep disturbance in spinocerebellar ataxias: is the SCA3 mutation a cause of restless legs syndrome?.
Neurology.
1998;
51
1603-1607
-
5
Winkelmann J, Muller-Myhsok B, Wittchen H U. et al .
Complex segregation analysis of restless legs syndrome provides evidence for an autosomal dominant mode of inheritance in early age at onset families.
Ann Neurol.
2002;
52
297-302
-
6
Walters A. Group IRLSS .
Towards a better definition of the restless legs syndrome.
Mov Disord.
1995;
10
634-642
-
7
Allen R P, Picchietti D, Hening W A. et al .
Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health.
Sleep Medicine.
2003;
4
101-119
-
8
Allen R P, Earley C J.
Augmentation of the restless legs syndrome with carbidopa/levodopa.
Sleep.
1996;
19
205-213
-
9
Earley C J, Yaffee J B, Allen R P.
Randomized, double-blind, placebo-controlled trial of pergolide in restless legs syndrome.
Neurology.
1998;
51
1599-1602
-
10
Montplaisir J, Nicolas A, Denesle R. et al .
Restless legs syndrome improved by pramipexole: a double-blind randomized trial.
Neurology.
1999;
52
938-943
-
11
Ondo W.
Ropinirole for restless legs syndrome.
Mov Disord.
1999;
14
138-140
-
12
Staedt J, Wassmuth F, Ziemann U. et al .
Pergolide: treatment of choice in restless legs syndrome (RLS) and nocturnal myoclonus syndrome (NMS). A double-blind randomized crossover trial of pergolide versus L-Dopa.
J Neural Transm.
1997;
104
461-468
-
13
Tergau F, Wischer S, Wolf C. et al .
Treatment of restless legs syndrome with the dopamine agonist alpha-dihydroergocryptine.
Mov Disord.
2001;
16
731-735
-
14
Walters A S, Hening W A, Kavey N. et al .
A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome.
Ann Neurol.
1988;
24
455-458
-
15
Wetter T C, Stiasny K, Winkelmann J. et al .
A randomized controlled study of pergolide in patients with restless legs syndrome.
Neurology.
1999;
52
944-950
Dr. med. W. Fogel
Fachbereich Neurologie und Klinische Neurophysiologie · Deutsche Klinik für Diagnostik
Aukammallee 33
65191 Wiesbaden
eMail: fogel.neuro@dkd-wiesbaden.de
